Skip to main content

Table 2 Comparison of data requirement for generics versus similar biological medicinal products. BE: bioequivalence; PMS: postmarketing study.

From: Current Status of Biosimilar Growth Hormone

Classic generics

Biosimilars

Manufacturing

Chemical synthesis

Genetically modified cell lines

 

Simple microbial fermentation

Complex fermentation process

 

Standard analytics

Complex purification process

  

Formulation

  

Complex analytical characterization

Preclinic

Generally none

In vitro/in vivo bioassay

  

Toxicity studies

  

Local tolerance studies

  

PK/PD studies

Clinic

Generally BE study

Phase I PK/PD

  

Phase III studies

  

Phase IIIb studies

  

Phase IV studes (PMS)